参考文献/References:
[1] Dik WA,Virakul S,van Steensel L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy[J].Exp Eye Res,2016,142:83-91.DOI:10.1016/j.exer.2015.02.007.
[2] Wiersinga WM,Regensburg NI,Mourits MP. Differential involvement of orbital fat and extraocular muscles in Graves' ophthalmopathy[J].Eur Thyroid J,2013,2(1):14-21.DOI:10.1159/000348246.
[3] Kumar S,Coenen MJ,Bahn RS,et al. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy[J].J Clin Endocrinol Metab,2004,89(2):930-935.DOI:10.1210/jc.2003-031427.
[4] Koumas L,Smith TJ,Feldon S,et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotype[J].Am J Pathol,2003,163(4):1291-1300.DOI:10.1016/S0002-9440(10)63488-8.
[5] Lehmann GM,Woeller CF,Pollock SJ,et al. Novel anti-adipogenic activity produced by human fibroblasts[J]. Am J Physiol Cell Physiol,2010,299(3):C672-C681.DOI:10.1152/ajpcell.00451.2009.
[6] Douglas RS,Afifiyan NF,Hwang CJ,et al. Increased generation of fibrocytes in thyroid-associated ophthalmopathy[J].J Clin Endocrinol Metab,2010,95(1):430-438.DOI:10.1210/jc.2009-1614.
[7] Khong JJ,McNab AA,Ebeling PR,et al. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms[J].Br J Ophthalmol,2016,100(1):142-150.DOI:10.1136/bjophthalmol-2015-307399.
[8] Kumar S,Nadeem S,Stan MN,et al. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy[J].J Mol Endocrinol,2011,46(3):155-163.DOI:10.1530/JME-11-0006.
[9] Yoon JS,Lee HJ,Chae MK,et al. Autophagy is involved in the initiation and progression of Graves' orbitopathy[J].Thyroid,2015,25(4):445-454.DOI:10.1089/thy.2014.0300.
[10] Kuriyan AE,Woeller CF,O'Loughlin CW,et al. Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype[J].Invest Opthalmol Vis Sci,2013,54(12):7370-7377.DOI:10.1167/iovs.13-12741.
[11] Zhao P,Deng Y,Gu P,et al. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy[J].Exp Eye Res,2013,107:65-73.DOI:10.1016/j.exer.2012.11.014.
[12] Douglas RS,Kahaly GJ,Patel A,et al. Teprotumumab for the treatment of active thyroid eye disease[J].N Engl J Med,2020,382(4):341-352.DOI:10.1056/NEJMoa1910434.
[13] Planck T,Shahida B,Parikh H,et al. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy[J].Thyroid,2014,24(10):1524-1532.DOI:10.1089/thy.2014.0153.
[14] Shahida B,Johnson PS,Jain R,et al. Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves ophthalmopathy patients[J].Endocr Connect,2019,8(9):1230-1239.DOI:10.1530/EC-19-0319.
[15] Li H,Fitchett C,Kozdon K,et al. Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments[J].PLoS One,2014,9(4):e95586.DOI:10.1371/journal.pone.0095586.
[16] Yang IH,Rose GE,Bailly M,et al. Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility[J].Sci Rep,2019,9(1):9622.DOI:10.1038/s41598-019-46075-1.
[17] Wan X,Helman LJ. The biology behind mTOR inhibition in sarcoma[J].Oncologist,2007,12(8):1007-1018.DOI:10.1634/theoncologist.12-8-1007.
[18] Ko J,Kim JY,Lee EJ,et al. Inhibitory effect of Idelalisib,a selective phosphatidylinositol 3-kinase δ inhibitor,on adipogenesis in an in vitro model of Graves' orbitopathy[J].Invest Opthalmol Vis Sci,2018,59(11):4477-4485.DOI:10.1167/iovs.18-24509.
[19] Park JR,Jung JW,Lee YS,et al. The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells[J].Cell Prolif,2008,41(6):859-874.DOI:10.1111/j.1365-2184.2008.00565.x.
[20] Kumar S,Leontovich A,Coenen MJ,et al. Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted Frizzled-related protein-1 in orbital adipogenesis[J].J Clin Endocrinol Metab,2005,90(8):4730-4735.DOI:10.1210/jc.2004-2239.
[21] Ezra DG,Krell J,Rose GE,et al. Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy[J].J Clin Pathol,2012,65(7):608-613.DOI:10.1136/jclinpath-2012-200719.
[22] Tao W,Ayala-Haedo JA,Field MG,et al. RNA-sequencing gene expression profiling of orbital adipose-derived stem cell population implicate[J].Invest Ophthalmol Vis Sci,2017,58(14):6146-6158.DOI:10.1167/iovs.17-22237.
[23] 冯会,孙建平,段薇. 甲状腺相关眼病治疗新进展[J].国际内分泌代谢杂志,2020,40(2):104-107.DOI:10.3760/cma.j.cn121383-20190904-09003
[24] Jefferis JM,Jones RK,Curie ZI,et al. Orbital decompression for thyroid eye disease:methods,outcomes,and complications[J].Eye(Lond),2018,32(3):626-636.DOI:10.1038/eye.2017.260.
[25] Markham A. Teprotumumab:first approval[J].Drugs,2020,80(5):509-512.DOI:10.1007/s40265-020-01287-y.
相似文献/References:
[1]胡晓娜,尹雅琪,谷伟军,等.TRAb水平与甲状腺相关性眼病活动度及严重程度的相关性分析[J].国际内分泌代谢杂志,2022,42(05):334.[doi:10.3760/cma.j.cn121383-20220306-03013]
Hu Xiaona,Yin Yaqi,Gu Weijun,et al.Correlation between TRAb and thyroid-associated ophthalmopathy activity/severity scores[J].International Journal of Endocrinology and Metabolism,2022,42(01):334.[doi:10.3760/cma.j.cn121383-20220306-03013]
[2]陆晨雅,陈国芳,徐书杭,等.甲状腺相关性眼病处理的新视角:局部注射疗法[J].国际内分泌代谢杂志,2023,43(02):104.[doi:10.3760/cma.j.cn121383-20210426-04068
]
Lu Chenya,Chen Guofang,Xu Shuhang,et al.Therapy insight: local injections for the treatment of thyroid associated ophthalmopathy[J].International Journal of Endocrinology and Metabolism,2023,43(01):104.[doi:10.3760/cma.j.cn121383-20210426-04068
]